Balyasny Asset Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,465
Closed -$93.6K 3129
2025
Q4
$93.6K Buy
+21,465
New +$116K ﹤0.01% 2964
2025
Q2
Sell
-35,633
Closed -$96.2K 3017
2025
Q1
$96.2K Buy
+35,633
New +$134K ﹤0.01% 2684

Other funds holding GNLX

Balyasny Asset Management's GNLX Position: Q1 2026 in Review

Balyasny Asset Management sold out of Genelux (GNLX) in Q1 2026, closing a stake of 21,465 shares — an estimated $93.6K sold.

Balyasny Asset Management first reported a position in GNLX in Q1 2025 and held it in 2 quarters. The position peaked at $96.2K in Q1 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Balyasny Asset Management reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 21,465 Genelux shares in Q1 2026, an estimated $93.6K.
  • Balyasny Asset Management first reported a position in Genelux in Q1 2025 and held it in 2 quarters.
  • Balyasny Asset Management's Genelux position peaked at $96.2K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.